ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA.

Murphy K.; Bensch G.; Berger W. E.; Engel M.; Schmidt H.; Moroni-Zentgraf P.; Kerstjens H. A.

首页> 外文期刊>Annals of allergy, asthma, and immunology >ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA.

【24h】

ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA.

机译：对吸入的皮质类固醇激素+/-长期服用β（2）激动剂的一次补全性噻托溴铵（R）可改善肺功能和哮喘控制，并减轻中度或重度哮喘患者的哮喘恶化风险。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology》 |2014年第1期|共1页
作者
Murphy K.; Bensch G.; Berger W. E.; Engel M.; Schmidt H.; Moroni-Zentgraf P.; Kerstjens H. A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA. [J] . Murphy K., Bensch G., Berger W. E., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：对吸入的皮质类固醇激素+/-长期服用β（2）激动剂的一次补全性噻托溴铵（R）可改善肺功能和哮喘控制，并减轻中度或重度哮喘患者的哮喘恶化风险。
2. Once-Daily Tiotropium Respimat Add-On to ICS+LABA Reduces Risk of Severe Exacerbation and Asthma Worsening in Patients With Asthma, Independent of Degree of Airflow Obstruction [J] . Donald Tashkin, Petra Moroni-Zentgraf, Michael Engel, Chest . 2014,第4期

机译：ICS + LABA的每日一次噻托溴铵增效药可降低哮喘患者严重加重和哮喘恶化的风险，与气流阻塞程度无关
3. ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO MAINTENANCE THERAPY IMPROVES LUNG FUNCTION IN PATIENTS WITH MODERATE OR SEVERE SYMPTOMATIC ASTHMA, INDEPENDENT OF T HELPER 2 INFLAMMATORY STATUS. [J] . Vandewalker M. L., Karpel J., Bensch G., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：补充一次难治性黄萎病呼吸疗法（R）可改善中度或重度症状性哮喘（独立于T HELPER 2炎症状态）的患者的肺功能。
4. Assessment of the long-duration effect of inhaled long-acting bronchodilator Salmeterol on cardiac autonomic control in adult asthma patients [C] . Tsou C.H., Kao T., Wang J.H., Computers in Cardiology, 2008 . 2008

机译：吸入长效支气管扩张剂沙美特罗对成人哮喘患者心脏自主控制的长期作用评估
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial) [O] . Paul K Keith, Caroline Koch, Michel Djandji, 2009

机译：孟鲁司特作为吸入性糖皮质激素或吸入性皮质类固醇与长效β-2-激动剂的附加疗法用于诊断为哮喘和并发性变应性鼻炎的患者（RADAR试验）
7. Safety and tolerability of once-daily tiotropium Respimat add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma [O] . Dahl, R., Szefler, S. J., Bernstein, J., 2015

机译：在中度或重度症状性哮喘的青少年患者中，至少每天一次吸入糖皮质激素维持治疗的噻托溴铵Respimat的安全性和耐受性
8. Comparison of Health Care Utilization and Costs Associated With Inhaled Corticosteroid Versus Beta(2)-Agonist Therapy in the Management of Asthma at Darnall Army Community Hospital [R] . Bui, T. P. 2000

机译：在Darnall陆军社区医院治疗哮喘的医疗保健利用和与吸入皮质类固醇相关的成本比较（2） - agonist疗法

ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA.

著录项

相似文献

相关主题

期刊订阅